Literature DB >> 2554115

Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites.

S B Liggett1, M Bouvier, W P Hausdorff, B O'Dowd, M G Caron, R J Lefkowitz.   

Abstract

As with many other receptor-effector systems, the responsiveness of the beta-adrenergic receptor (beta AR)/adenylyl cyclase system undergoes desensitization upon agonist exposure. Phosphorylations of the receptor by the cAMP-dependent protein kinase (protein kinase A) and the beta AR kinase appear to play roles in such desensitization phenomena, but the functional significance of the receptor phosphorylation in intact cells has not been previously assessed. In this study, we constructed and expressed in a mammalian fibroblast line the normal (wild type) human beta 2 AR and mutant forms of the receptor that lack the putative phosphorylation sites for these two protein kinases. The two consensus sequences for phosphorylation by protein kinase A were altered by changing serines 261, 262 and 345, 346 to alanines. In another mutant, the 11 serines and threonines at the carboxy terminus of the protein that constitute the putative beta AR kinase phosphorylation sites were changed to alanines or glycines. The mutated receptors did not differ from the wild type in their affinities for agonists or antagonists or in their ability to mediate agonist stimulation of adenylyl cyclase. Moreover, their levels of expression in the cultured cells were the same. When stimulated with the beta AR agonist isoproterenol, cells bearing either the wild type or mutant receptors generated cAMP at essentially identical rates for the first 2 min. Cells bearing wild type receptors then showed a rapid desensitization characterized by a markedly diminished rate of cAMP production after the first few minutes of stimulation. However, cells bearing either of the mutated forms of the receptor showed much less desensitization and continued to generate cAMP at a rate 3-4 times greater than that observed in cells expressing the wild type receptor. In contrast, intact cell cAMP levels stimulated by prostaglandin E1 and forskolin were not different between cells bearing wild type or mutant beta AR. These results suggest an important physiological role for phosphorylation of the beta AR in regulating rapid agonist-induced desensitization in intact cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554115

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

1.  Importance of regions outside the cytoplasmic tail of G-protein-coupled receptors for phosphorylation and dephosphorylation.

Authors:  Austin U Gehret; Patricia M Hinkle
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

Review 2.  Structure and function of G protein coupled receptors.

Authors:  J Lameh; R I Cone; S Maeda; M Philip; M Corbani; L Nádasdi; J Ramachandran; G M Smith; W Sadée
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

3.  β(2)-Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail.

Authors:  Nodi Dehvari; Dana S Hutchinson; Julia Nevzorova; Olof S Dallner; Masaaki Sato; Martina Kocan; Jon Merlin; Bronwyn A Evans; Roger J Summers; Tore Bengtsson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Modulation of murine melanocyte function in vitro by agouti signal protein.

Authors:  C Sakai; M Ollmann; T Kobayashi; Z Abdel-Malek; J Muller; W D Vieira; G Imokawa; G S Barsh; V J Hearing
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

5.  Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization.

Authors:  M Shih; C C Malbon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

6.  Leukocyte-Expressed β2-Adrenergic Receptors Are Essential for Survival After Acute Myocardial Injury.

Authors:  Laurel A Grisanti; Anna M Gumpert; Christopher J Traynham; Joshua E Gorsky; Ashley A Repas; Erhe Gao; Rhonda L Carter; Daohai Yu; John W Calvert; Andrés Pun García; Borja Ibáñez; Joseph E Rabinowitz; Walter J Koch; Douglas G Tilley
Journal:  Circulation       Date:  2016-06-30       Impact factor: 29.690

7.  Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements.

Authors:  R F Thomas; B D Holt; D A Schwinn; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

8.  A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.

Authors:  Stephen B Liggett; Sharon Cresci; Reagan J Kelly; Faisal M Syed; Scot J Matkovich; Harvey S Hahn; Abhinav Diwan; Jeffrey S Martini; Li Sparks; Rohan R Parekh; John A Spertus; Walter J Koch; Sharon L R Kardia; Gerald W Dorn
Journal:  Nat Med       Date:  2008-04-20       Impact factor: 53.440

9.  Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors.

Authors:  Richard Einstein; Heather Jordan; Weiyin Zhou; Michael Brenner; Esther G Moses; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

10.  Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.

Authors:  S B Liggett; N J Freedman; D A Schwinn; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.